Tempest Therapeutics cuts 21 of 26 full-time staff, initiates strategic review

Tempest Therapeutics, Inc.

Workforce reduced by 21 of 26 full-time employees, effective April 30, 2025.
Estimated $1.5M in cash severance and benefit costs, mostly in Q2 2025.
Key affected employees to transition to consulting agreements.
Company initiated process to explore strategic alternatives to extend capital resources.

item 2.05

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-085773
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2025-04-18T23:59:59+00:00
discovered_at: 2026-05-14T18:02:48.711203+00:00
generated_at: 2026-05-23T10:59:07.982968+00:00
sec_items: ["2.05"]
event_type: other_material
sentiment: negative
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-085773
json_url: https://secwatch.observer/filing/0001193125-25-085773.json
markdown_url: https://secwatch.observer/filing/0001193125-25-085773.md
text_url: https://secwatch.observer/filing/0001193125-25-085773.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312525085773/0001193125-25-085773-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312525085773/d792758d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-085773

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.